Ftse Mib
37.675,40
-1,44%
DAX
22.328,77
-1,23%
S&P 500
5.572,07
-0,76%
NASDAQ
17.436,10
-0,18%
Bitcoin
82.864,24
5,59%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Ginkgo Bioworks Holdings Inc (DNA) Ginkgo Bioworks Holdings Inc (DNA) Notizie

Ginkgo Bioworks Holdings Inc

DNA
6,94
-0,01 (-0,14%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 21:35:56
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/3/202517:03EDGAR2Form 144 - Report of proposed sale of securities
10/3/202522:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/3/202522:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/3/202514:46EDGAR2Form 144 - Report of proposed sale of securities
07/3/202515:43EDGAR2Form 144 - Report of proposed sale of securities
06/3/202523:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202523:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202516:14EDGAR2Form 144 - Report of proposed sale of securities
25/2/202523:00PRNUSGinkgo Bioworks Reports Fourth Quarter and Full Year 2024..
21/2/202515:00PRNUSGinkgo Bioworks integrates Callisto for..
20/2/202514:01PRNUSGinkgo Bioworks Partners with HaDEA in Up to €24 Million..
18/2/202514:00PRNUSGinkgo Bioworks Announces Date of Fourth Quarter and Full..
12/2/202515:45EDGAR2Form 144 - Report of proposed sale of securities
11/2/202516:53EDGAR2Form 144 - Report of proposed sale of securities
06/2/202516:23EDGAR2Form 144 - Report of proposed sale of securities
06/2/202514:01PRNUSGinkgo Bioworks to Host 6th Annual Ferment as Boston-based..
23/1/202514:01PRNUSGinkgo Automation to Deploy Flexible Laboratory Automation..
13/1/202514:01PRNUSGinkgo Bioworks Partners with Universal Cells, an Astellas..
09/1/202514:00PRNUSGinkgo Bioworks Announces Participation in the 43rd Annual..
02/1/202517:00EDGAR2Form 144 - Report of proposed sale of securities
31/12/202415:36EDGAR2Form 144 - Report of proposed sale of securities
30/12/202415:55EDGAR2Form 144 - Report of proposed sale of securities
27/12/202416:43EDGAR2Form 144 - Report of proposed sale of securities
26/12/202417:46EDGAR2Form 144 - Report of proposed sale of securities
26/12/202414:18EDGAR2Form 144 - Report of proposed sale of securities
23/12/202415:42EDGAR2Form 144 - Report of proposed sale of securities
17/12/202414:11PRNUSGinkgo Bioworks Awarded $9.4 Million in Partnership with..
29/11/202417:11EDGAR2Form 144 - Report of proposed sale of securities
27/11/202416:09EDGAR2Form 144 - Report of proposed sale of securities
26/11/202415:45EDGAR2Form 144 - Report of proposed sale of securities
25/11/202416:39EDGAR2Form 144 - Report of proposed sale of securities
22/11/202415:53EDGAR2Form 144 - Report of proposed sale of securities
21/11/202417:30EDGAR2Form 144 - Report of proposed sale of securities
20/11/202416:06EDGAR2Form 144 - Report of proposed sale of securities
19/11/202416:20EDGAR2Form 144 - Report of proposed sale of securities
18/11/202416:10EDGAR2Form 144 - Report of proposed sale of securities
14/11/202417:23EDGAR2Form 144 - Report of proposed sale of securities
12/11/202423:01PRNUSGinkgo Bioworks Reports Third Quarter 2024 Financial Results
12/11/202414:01PRNUSGinkgo Bioworks Advances Collaboration with Merck to Improve..
08/11/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202423:17EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/11/202415:57EDGAR2Form 144 - Report of proposed sale of securities
06/11/202415:38EDGAR2Form 144 - Report of proposed sale of securities
05/11/202415:40EDGAR2Form 144 - Report of proposed sale of securities
05/11/202413:00PRNUSGinkgo Bioworks Announces Date of Third Quarter 2024 Results..
30/10/202414:43EDGAR2Form 144 - Report of proposed sale of securities
29/10/202414:46EDGAR2Form 144 - Report of proposed sale of securities
18/10/202416:55EDGAR2Form 144 - Report of proposed sale of securities
17/10/202416:43EDGAR2Form 144 - Report of proposed sale of securities
16/10/202416:41EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 6,98 Min: 6,585 Max: 7,08
Chiusura: 6,95

La tua Cronologia

NYSE
DNA
Ginkgo Bioworks
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci